Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.03M Buy
3,730
+21
+0.6% +$10.8K 0.04% 383
2026
Q1
$1.61M Buy
3,709
+77
+2% +$33.9K 0.04% 418
2025
Q4
$1.19M Buy
3,632
+363
+11% +$117K 0.03% 503
2025
Q3
$1.04M Sell
3,269
-258
-7% -$71.2K 0.03% 367
2025
Q2
$971K Buy
3,527
+463
+15% +$94.2K 0.03% 408
2025
Q1
$565K Sell
3,064
-40
-1% -$9.24K 0.04% 304
2024
Q4
$611K Buy
+3,104
New +$597K 0.04% 334

Other funds holding NVMI

Callan Family Office's NVMI Position: Q2 2026 in Review

Callan Family Office increased its Nova (NVMI) stake by 0.57% in Q2 2026, buying an estimated $10.8K and bringing the position to 3,730 shares worth $2.03M. The position accounts for 0.04% of the portfolio, ranked #383.

Callan Family Office first reported a position in NVMI in Q4 2024 and has held it in 7 quarters since. 345 funds tracked by Wall St. Rank hold NVMI as of Q2 2026.

  • Callan Family Office held 3,730 shares of Nova worth $2.03M as of Q2 2026.
  • Callan Family Office bought 21 Nova shares in Q2 2026, an estimated $10.8K.
  • Nova made up 0.04% of Callan Family Office's portfolio in Q2 2026, its #383 holding.
  • Callan Family Office first reported a position in Nova in Q4 2024 and has held it in 7 quarters since.
  • 345 funds tracked by Wall St. Rank held Nova as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.